Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Olon’s strategy for being resilient in times of instability.
Released By Olon Spa
March 18, 2024
What is the emerging geopolitical scenario, and what effects does it have on global and interconnected pharmaceutical supply chains? The COVID-19 pandemic undeniably marked the start of a new era of “polycrisis,” characterized by continuous, frequent, and devastating crises. Olon—a leading active pharmaceutical ingredient (API) supplier headquartered in Italy and with a global manufacturing network comprising 11 production sites and 7 research centers worldwide—has discovered the key to transforming crises into opportunities and making its complex operational model resilient and flexible: diversification and a multi-center approach. The mantra in supply chain management, according to Olon Group’s head of global strategic planning and supply chain, Cristiano Capriotti, has long been reduce, reduce, reduce. “Reduce costs, reduce production centers, reduce the number of suppliers, and reduce stocks of raw materials,” he said. “However, this pursuit of leanness has also brought with it the risk of diminished resilience, reducing the extra capacity of the production system, pushing the ‘just-in-time’ approach to extremes, and forcing the system on decreasing costs and strategic options. This has centralized production in a handful of large hubs of maximized production and distribution, with substantial long-term investments, to achieve maximum efficiency.” But being lean does not always allow you to be responsive to the market, particularly in situations of continued instability, such as we are experiencing today and will continue to experience for some time, according to Capriotti. “Historically—not just since the crisis—at Olon we have seen the elimination of suppliers as a decrease in the company’s wealth and in the ability of being agile and responsive,” he explained. “Through great investment from the entire organization, including regulatory, QA, R&D, and operations sectors, we have pursued a structured Assurance of Supply program based on continuous risk analysis and the diversification of geopolitical areas of suppliers, and keeping European suppliers whenever possible. We have adhered to the principle of not being dependent on one single region, which can cause unforeseen problems and supply disruption, such as the closure of connecting channels or global political happenings affecting the circulation of goods that we are seeing today.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !